alprostadil

The drug is used for the treatment of adults with chronic arterial disease stage III and IV (according to the Fontaine classification) who are not candidates for revascularization or for whom revascularization has been unsuccessful.

Form: concentrate for infusion solution

ATC: C01EA01

Manufacturer: BEG Health Care GmbH (manufacturer responsible for manufacturing unpackaged products, primary and secondary packaging)

The drug is used for the treatment of chronic arterial diseases (stages III and IV) in adults if revascularization is impossible or has not yielded results.

Form: powder for solution for infusion

ATC: C01EA01

Manufacturer: Aescica Pharmaceuticals GmbH (quality control of unpackaged products, responsible for batch release; secondary packaging)

The drug is used for the treatment of stage III chronic arterial diseases (according to the Fontaine classification) that are not amenable to revascularization or if revascularization has been unsuccessful.

Form: powder for solution for infusion

ATC: C01EA01

Manufacturer: Aescica Pharmaceuticals GmbH (quality control of unpackaged products, responsible for batch release; secondary packaging)

The drug is used for the treatment of adults with chronic peripheral arterial disease (Fontaine stages III and IV) who are not candidates for revascularization or for whom revascularization was unsuccessful.

Form: powder for solution for infusion

ATC: C01EA01

Manufacturer: K.T. Rompharm Company S.R.L. (manufacturing, primary packaging; secondary packaging, raw material and material control, intermediate product control, finished product control, batch release)

The drug is used for the treatment of adults with chronic peripheral artery disease (stages III and IV) if other vasodilation methods are impossible or have not yielded results.

Form: concentrate for infusion solution

ATC: C01EA01

Manufacturer: JSC "Kevelt"